Medicare seeks to negotiate prices on 15 drugs, including Novo Nordisk’s (NVO) GLP-1 weight-loss drugs Ozempic and Wegovy, in new talks. Yahoo Finance senior health reporter Anjalee Khemlani explains the process and the range of other drugs on this new list from pharmaceutical giants Pfizer (PFE), AstraZeneca (AZN), Merck (MRK) To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Luke Carberry Mogan.
Medicare to negotiate prices on 15 drugs, including Ozempic
January 17, 2025
You may also like
Indices by TradingView
Why Symbotic is the better robotics pick — not Tesla
July 1, 2025
Trending tickers: Tesla, Robinhood, Oracle, Apple
July 1, 2025
Categories
Indices by TradingView